1 | Acetate | [1] Acetate Acetate | - | - | - | [41] 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
|
2 | ADVATE | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
3 | ADVATE (rAHF - PFM) | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
4 | ADVATE (rAHF-PFM) | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
5 | ADVATE 1000 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
6 | ADVATE 1000IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
7 | ADVATE 500 IU powder and solvent for solution for injection | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
8 | Alphanate | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
9 | Alphanate 1000 I.U. | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
10 | Alphanate 1500 I.U. | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
11 | Alphanate SD/HT | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
12 | ALPHANATE*INF 1F 1000UI+F 10ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
13 | ALPHANATE*INF 1F 1500UI+F 10ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
14 | ALPHANATE*INF 1F 250UI+F 5ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
15 | ALPHANATE*INF 1F 500UI+F 5ML | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
16 | Antihemophilic Factor (Recombinant) | - | - | - | - | [1] 288 288 💬
|
17 | APCC, aPCC + TXA | - | - | - | - | [1] 288 288 💬
|
18 | ARC 1779 | - | - | - | - | [2] 64 64, 288 💬
|
19 | ARC1779 | - | - | - | - | [2] 64 64, 288 💬
|
20 | ARC1779 Injection | - | - | - | - | [2] 64 64, 288 💬
|
21 | BAX 111 | - | - | - | - | [1] 288 288 💬
|
22 | BAX111 | - | - | - | - | [1] 288 288 💬
|
23 | Biostate | - | - | - | - | [1] 288 288 💬
|
24 | Biostate® | - | - | - | - | [1] 288 288 💬
|
25 | BIVV001 (rFVIIIFc-VWF-XTEN) | - | - | - | - | [1] 288 288 💬
|
26 | Blood coagulation Factor VIII and vWF, human | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
27 | Blood sample | - | - | - | - | [20] 8 8, 13, 46, 49, 51, 53, 61, 66, 84, 88, 96, 97, 107, 127, 235, 274, 280, 288, 294, 299 💬
|
28 | BORTEZOMIB | [2] Bortezomib Bortezomib, Bortezomib D-mannitol | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [17] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬
|
29 | Catridecacog | [1] Catridecacog Catridecacog | [1] Catridecacog
Catridecacog
💬
| - | - | [2] 97 97, 288 💬
|
30 | Chloride | [1] Chloride ion Chloride ion | - | - | - | [28] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 💬
|
31 | Cluvot | - | - | - | - | [1] 288 288 💬
|
32 | Coagadex | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
33 | Coagulación factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
34 | Coagulation factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
35 | Coagulation factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
36 | Coagulation factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
37 | CoFactor | - | - | - | - | [2] 265 265, 288 💬
|
38 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 205, 222, 224, 256, 274, 283, 284, 285, 288, 326, 331 💬
|
39 | DDAVP | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 75 75, 288 💬
|
40 | DDAVP (Desmopressin) | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [1] 288 288 💬
|
41 | Desmopressin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [5] 6 6, 64, 72, 225, 288 💬
|
42 | Desmopressin acetate | [2] Acetate Acetate, Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
43 | Desmopressine | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 225 225, 288 💬
|
44 | Efanesoctocog alfa | [1] Efanesoctocog alfa Efanesoctocog alfa | [1] Efanesoctocog alfa
Efanesoctocog alfa
💬
| - | - | [1] 288 288 💬
|
45 | Emicizumab | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
46 | Emicizumab (ACE910, RO5534262) | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
47 | Emicizumab Injection | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
48 | Eqwilate | - | - | - | - | [1] 288 288 💬
|
49 | F13CD | - | - | - | - | [1] 288 288 💬
|
50 | F8VR | - | - | - | - | [1] 288 288 💬
|
51 | FACTANE 200 IU/ml | - | - | - | - | [1] 288 288 💬
|
52 | Factor VIII | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
53 | Factor VIII concentrate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
54 | Factor von Willebrand | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
55 | FACTOR X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
56 | Factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [3] 51 51, 97, 288 💬
|
57 | Factor XIII Concentrate (Human) | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
58 | Factor XIII Concentrate (Human), Pasteurized | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
59 | Fanhdi | - | - | - | - | [1] 288 288 💬
|
60 | FANHDI 100 UI | - | - | - | - | [1] 288 288 💬
|
61 | Fanhdi 100 UI FVIII-120 UI FVW | - | - | - | - | [1] 288 288 💬
|
62 | FANHDI 25 UI | - | - | - | - | [1] 288 288 💬
|
63 | Fanhdi 25 UI FVIII-30 UI FVW | - | - | - | - | [1] 288 288 💬
|
64 | FANHDI 250UI*1F 250UI+F 10ML | - | - | - | - | [1] 288 288 💬
|
65 | FANHDI 50 UI | - | - | - | - | [1] 288 288 💬
|
66 | Fanhdi 50 UI FVIII-60 UI FVW | - | - | - | - | [1] 288 288 💬
|
67 | FANHDI*INF FL 250UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬
|
68 | FANHDI*INF FL 500UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬
|
69 | FANHDI*INF FL1000UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬
|
70 | FANHDI*INF FL250UI+SIR SOLV+S | - | - | - | - | [1] 288 288 💬
|
71 | Fibrogammin P | - | - | - | - | [1] 288 288 💬
|
72 | Fibrogammin® P | - | - | - | - | [1] 288 288 💬
|
73 | Fibrogammin®P | - | - | - | - | [1] 288 288 💬
|
74 | FXIII Concentrate (Human) | - | - | - | - | [1] 288 288 💬
|
75 | FXIII Concentrate (Human) (FXIII) | - | - | - | - | [1] 288 288 💬
|
76 | Haemate P | - | - | - | - | [1] 288 288 💬
|
77 | Haemate P® (Human Coagulation Factor VIII) | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
78 | Haemate-P, Wilate | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
79 | Haemate® P 250 | - | - | - | - | [1] 288 288 💬
|
80 | Hemlibra | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
81 | Hemlibra® | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
82 | HEMOFIX | - | - | - | - | [1] 288 288 💬
|
83 | HUMAN COAGULATION FACTOR VIII | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
84 | Human coagulation Factor VIII / von Willebrand Factor | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
85 | Human coagulation factor VIII associated with Von Willebrand factor (VWF) | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
86 | Human Coagulation Factor VIII, Von Willebrand Factor | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
87 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND FACTOR COMPLEX | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
88 | HUMAN COAGULATION FACTOR VIII, VON WILLEBRAND HUMAN COAGULATION FACTOR | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
89 | Human Coagulation FACTOR X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
90 | Human factor X | [1] Coagulation factor X human Coagulation factor X human | - | - | - | [1] 288 288 💬
|
91 | HUMAN VON WILLEBRAND FACTOR | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
92 | Human von Willebrand factor (VWF) and coagulation factor VIII (FVIII) | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
93 | Human VWF/FVIII concentrate | - | - | - | - | [1] 288 288 💬
|
94 | Humate-P | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
95 | IL-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
96 | Interleukin 11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
97 | Interleukin-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [2] 96 96, 288 💬
|
98 | Marketed plasma-derived VWF/FVIII concentrate | - | - | - | - | [1] 288 288 💬
|
99 | Minirin | [1] Desmopressin Desmopressin | [1] Desmopressin
Desmopressin
💬
| [2] AVPR2 AVPR2, F8 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | [2] 64 64, 288 💬
|
100 | Minrin | - | - | - | - | [1] 288 288 💬
|
101 | Natriumchlorid | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 288 288 💬
|
102 | Natriumchlorid 0,9 % | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 288 288 💬
|
103 | Neumega (Oprelvekin, Interleukin 11, IL-11) | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
104 | NN 1841 | - | - | - | - | [1] 288 288 💬
|
105 | NN1841 | - | - | - | - | [1] 288 288 💬
|
106 | OBI-1 | - | - | - | - | [1] 288 288 💬
|
107 | OBIZUR | [1] Susoctocog alfa Susoctocog alfa | [1] Susoctocog alfa
Susoctocog alfa
💬
| - | - | [1] 288 288 💬
|
108 | Obyoctocog alfa | - | - | - | - | [1] 288 288 💬
|
109 | Octanate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
110 | OCTANATE 100 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
111 | OCTANATE 50 UI/ml, poudre et solvant pour solution injectable | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
112 | OCTOCOG ALFA | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
113 | Octostim | - | - | - | - | [2] 64 64, 288 💬
|
114 | Oprelvekin | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
115 | Oprelvekin, Interleukin 11, IL-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
116 | Optivate | - | - | - | - | [1] 288 288 💬
|
117 | Optivate® (Human Coagulation Factor VIII) | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
118 | Physiologische Kochsalzlösung Fresenius - Infusionslösung | - | - | - | - | [1] 288 288 💬
|
119 | Phytomenadione | [1] Phylloquinone Phylloquinone | - | - | - | [1] 288 288 💬
|
120 | Plasma-derived FVIII/VWF concentrate | - | - | - | - | [1] 288 288 💬
|
121 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331 💬
|
122 | Prothrombin | [1] Prothrombin Prothrombin | - | - | - | [1] 288 288 💬
|
123 | Prothrombin Complex Concentrate | [2] Factor IX Complex (Human) Factor IX Complex (Human), Prothrombin | - | - | - | [1] 288 288 💬
|
124 | RAHF | [1] Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | - | - | - | [1] 288 288 💬
|
125 | Recombinant coagulation FVIII Fc – von Willebrand factor – XTEN fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
126 | Recombinant coagulation FVIII Fc –von Willebrand factor – XTEN fusion protein | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
127 | Recombinant factor VIIII (rFVIII) | - | - | - | - | [1] 288 288 💬
|
128 | Recombinant Factor XIII | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [1] 288 288 💬
|
129 | Recombinant Factor XIII (rFXIII) | [1] Factor XIII (human) Factor XIII (human) | - | - | - | [2] 97 97, 288 💬
|
130 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTO | [2] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa | - | - | - | [1] 288 288 💬
|
131 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
132 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR - XTEN FUSION PROTEIN | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
133 | RECOMBINANT HUMAN COAGULATION FACTOR VIII FC - VON WILLEBRAND FACTOR -XTEN FUSION PROTEIN | [3] Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
134 | Recombinant human von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
135 | Recombinant interleukin-11 | [1] Oprelvekin Oprelvekin | [1] Oprelvekin
Oprelvekin
💬
| [1] IL11RA IL11RA 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | [1] 288 288 💬
|
136 | Recombinant porcine coagulation factor VIII (B domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
137 | Recombinant porcine coagulation factor VIII (B-domain deleted) | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
138 | Recombinant von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
139 | Recombinant von Willebrand Factor (rVWF) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
140 | Recombinant von Willebrand Factor 1300IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
141 | Recombinant von Willebrand Factor 650IU | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
142 | Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
143 | Recomibnant human Von Willebrand Factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
144 | RFVIIa | [1] Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1] 288 288 💬
|
145 | RFVIIa, rFVIIa + TXA | [1] Coagulation factor VIIa Recombinant Human Coagulation factor VIIa Recombinant Human | - | - | - | [1] 288 288 💬
|
146 | RFVIII | - | - | - | - | [1] 288 288 💬
|
147 | Rituxan | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [4] 46 46, 60, 256, 288 💬
|
148 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [48] 11 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
149 | RO5534262 EMICIZUMAB | [1] Emicizumab Emicizumab | [1] Emicizumab
Emicizumab
💬
| [2] F10 F10, F9 💬
| [1] Complement and coagulation cascades Complement and coagulation cascades 💬 | [1] 288 288 💬
|
150 | Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol Rurioctocog alfa pegol | [1] Rurioctocog alfa pegol
Rurioctocog alfa pegol
💬
| - | - | [1] 288 288 💬
|
151 | RVWF | - | - | - | - | [1] 288 288 💬
|
152 | Saline solution | - | - | - | - | [4] 2 2, 34, 288, 299 💬
|
153 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
|
154 | Simvastatine | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [3] 6 6, 13, 288 💬
|
155 | Sodium chloride | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [20] 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 168, 193, 227, 228, 288, 299 💬
|
156 | SODIUM CHLORIDE SOLUTION 0.9% | [2] Chloride ion Chloride ion, Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 51 51, 60, 288, 299 💬
|
157 | Standard of Care for Haemophilia A | - | - | - | - | [1] 288 288 💬
|
158 | Standard of Care FVIII Replacement therapy | - | - | - | - | [1] 288 288 💬
|
159 | Steroid | - | - | - | - | [2] 107 107, 288 💬
|
160 | TAK-672 | - | - | - | - | [1] 288 288 💬
|
161 | Tranexamic acid | [1] Tranexamic acid Tranexamic acid | [1] Tranexamic acid
Tranexamic acid
💬
| [1] PLG PLG 💬
| [4] Complement and coagulation cascades Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬 | [7] 46 46, 70, 215, 227, 274, 288, 299 💬
|
162 | VEYONDI 650IU powder and solvent for solution for injection | - | - | - | - | [1] 288 288 💬
|
163 | Veyvondi | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
164 | VEYVONDI 1300 IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
165 | VEYVONDI 1300I IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
166 | VEYVONDI 1300IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
167 | VEYVONDI 650IU powder and solvent for solution for injection | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
168 | Von willebrand factor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [2] 64 64, 288 💬
|
169 | Von Willebrand factor (Recombinant) | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
170 | Von Willebrand factor and coagulation factor VIII in combination | [2] Beroctocog alfa Beroctocog alfa, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
171 | Von Willebrand Factor Antigen | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
172 | Von Willebrand Factor Ristocetin Cofactor | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
173 | Von Willebrand Faktor | - | - | - | - | [1] 288 288 💬
|
174 | Voncento | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
175 | Voncento, Biostate® | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
176 | Voncento® | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
177 | VONICOG ALFA | [1] Vonicog alfa Vonicog alfa | [1] Vonicog alfa
Vonicog alfa
💬
| - | - | [1] 288 288 💬
|
178 | VWD factor VIII concentrate | [1] Beroctocog alfa Beroctocog alfa | - | - | - | [1] 288 288 💬
|
179 | VWF gene analysis | - | - | - | - | [1] 288 288 💬
|
180 | VWF replacement therapy with Wilate | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
181 | VWF SD-35-DH | - | - | - | - | [1] 288 288 💬
|
182 | VWF-containing products | - | - | - | - | [1] 288 288 💬
|
183 | VWF/FVIII products | - | - | - | - | [1] 288 288 💬
|
184 | WILATE | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
185 | Wilate 1000 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
186 | WILATE 1000 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
187 | WILATE 450 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
188 | Wilate 500 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
189 | WILATE 500 I.U. | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
190 | WILATE 900 | [2] Antihemophilic factor human Antihemophilic factor human, Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
191 | WILATE® 450 | [1] Von Willebrand factor human Von Willebrand factor human | - | - | - | [1] 288 288 💬
|
192 | WILFACTIN | - | - | - | - | [1] 288 288 💬
|
193 | Willfact | - | - | - | - | [1] 288 288 💬
|
194 | Wiloctin | - | - | - | - | [1] 288 288 💬
|